Group One Trading
LXEO icon

Group One Trading’s Lexeo Therapeutics LXEO Stock Holding History

Group One Trading’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,000
Closed -$19.9K – 8260
2025
Q4 		$19.9K Sell
2,000
-900
-31% -$8.21K ﹤0.01% 6342
2025
Q3 		$19.3K Buy
+2,900
New +$14K ﹤0.01% 6718

Other funds holding LXEO

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Group One Trading's LXEO Position: Q2 2026 in Review

Group One Trading reduced its Lexeo Therapeutics (LXEO) stake by 15% in Q2 2026, selling an estimated $1.08K and leaving 1,109 shares worth $5.16K. The position accounts for ﹤0.01% of the portfolio, ranked #6720.

Group One Trading first reported a position in LXEO in Q4 2025 and has held it in 3 quarters since. The position peaked at $18K in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.

  • Group One Trading held 1,109 shares of Lexeo Therapeutics worth $5.16K as of Q2 2026.
  • Group One Trading sold 199 Lexeo Therapeutics shares in Q2 2026, an estimated $1.08K.
  • Lexeo Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6720 holding.
  • Group One Trading first reported a position in Lexeo Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Group One Trading's Lexeo Therapeutics position peaked at $18K in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.